Chengda Pharmaceuticals (301201.SZ) faces a reduction of 860,000 shares by its major shareholder, Qianhai Shengtai.

Chengda Pharmaceuticals (301201.SZ) announced that its shareholder, Qianhai Shengtai, holding more than 5% of the shares, will reduce its holding of 860,000 shares of the company through block trading from March 6, 2025 to March 11, 2025, representing 0.57% of the total share capital of the company after excluding the shares held in the repurchase account.